ENBI:CA Entheon Biomedical Corp

CAD 0.28 +0.10 ( +51.35%)
Icon

Entheon Biomedical Corp (ENBI:CA) Financial Statements

COMMON STOCK | Biotechnology | CNSX
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.28

+0.10 (+51.35%)

CAD 1.42M

0.03M

CAD -1.00

N/A

Icon

ENBI:CA

Entheon Biomedical Corp (CAD)
COMMON STOCK | CNSX
CAD 0.28
+0.10 ( +51.35%)

Entheon Biomedical Corp (ENBI:CA) Annual Income Statement ()

ENBI:CA Quarterly Financials ()

Frequently Asked Questions About Entheon Biomedical Corp (ENBI:CA) Stock

Entheon Biomedical Corp's (ENBI:CA) last reported annual revenue was CAD 189677.00.

Entheon Biomedical Corp's (ENBI:CA) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

Entheon Biomedical Corp's(ENBI:CA) is not profitable as of its last reported annual financials.

The net profit margin for Entheon Biomedical Corp's(ENBI:CA) from its laster reported year is -4492.23%

The return on equity (ROE) for Entheon Biomedical Corp's(ENBI:CA) from its last reported annual financials is : -99.51%

The return on assets (ROA) for Entheon Biomedical Corp's(ENBI:CA) from its last reported annual financials is : -59.42%

The return on invested capital (ROIC) for Entheon Biomedical Corp's(ENBI:CA) from its last reported annual financials is : -74.51%

The Debt to Equity ratio for Entheon Biomedical Corp's(ENBI:CA) from its last reported annual financials is : 0.00%

The dividend yield for Entheon Biomedical Corp's(ENBI:CA) from its laster reported year is 0.00%

Entheon Biomedical Corp's(ENBI:CA) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...